Please provide your email address to receive an email when new articles are posted on . A sirolimus-eluting balloon was noninferior to drug-eluting stents in treating de novo coronary lesions. The ...
Results from the first randomized clinical trial in the United States to compare a sirolimus-eluting balloon (DEB) to a control group consisting of drug-eluting stent (DES) and balloon angioplasty (BA ...
Cardiologists explain when angioplasty can be life-saving, when medicines may be enough and why finding a blockage does not ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved a paclitaxel-coated balloon as an alternative treatment of coronary in-stent restenosis. The ...
A new drug-eluting balloon can perform just as well as the standard treatment for patients with coronary in-stent restenosis (ISR) undergoing repeated percutaneous coronary intervention (PCI). These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results